Saturday, December 03, 2016
 
 
Video: Page (1) of 1 - 04/27/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Regeneron Up 25% On Positive Phase III Cancer Drug Trial

By DMO Affiliate
Regeneron Pharmaceuticals (NASDAQ:REGN) soared over 40% at one point Wednesday afternoon, after the company reported positive results from a Phase III study for its drug Zaltrap.The drug, in combination with chemotherapy, helped patients with advanced col
Regeneron Up 25% On Positive Phase III Cancer Drug Trial




Page: 1


null
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines